ID   EPHA5_HUMAN             Reviewed;        1037 AA.
AC   P54756; Q7Z3F2;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   22-SEP-2009, sequence version 3.
DT   02-NOV-2010, entry version 119.
DE   RecName: Full=Ephrin type-A receptor 5;
DE            EC=2.7.10.1;
DE   AltName: Full=EPH homology kinase 1;
DE            Short=EHK-1;
DE   AltName: Full=EPH-like kinase 7;
DE            Short=EK7;
DE            Short=hEK7;
DE   Flags: Precursor;
GN   Name=EPHA5; Synonyms=EHK1, HEK7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9191074; DOI=10.1016/S0169-328X(96)00268-9;
RA   Miescher G.C., Taylor V., Olivieri G., Mindermann T., Shrock E.,
RA   Steck A.J.;
RT   "Extensive splice variation and localization of the EHK-1 receptor
RT   tyrosine kinase in adult human brain and glial tumors.";
RL   Brain Res. Mol. Brain Res. 46:17-24(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Retina;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 25-1037.
RC   TISSUE=Brain;
RX   MEDLINE=95206782; PubMed=7898931;
RA   Fox G.M., Holst P.L., Chute H.T., Lindberg R.A., Janssen A.M.,
RA   Basu R., Welcher A.A.;
RT   "cDNA cloning and tissue distribution of five human EPH-like receptor
RT   protein-tyrosine kinases.";
RL   Oncogene 10:897-905(1995).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-833, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-833, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [7]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-81; ALA-235; GLN-330; GLN-417;
RP   LYS-503; CYS-506; GLU-582; THR-672; THR-673; ILE-856; ARG-959 AND
RP   SER-1032.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Receptor for members of the ephrin-A family. Binds to
CC       ephrin-A1, -A2, -A3, -A4 and -A5.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Additional isoforms seem to exist;
CC       Name=1;
CC         IsoId=P54756-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P54756-2; Sequence=VSP_002999;
CC       Name=3;
CC         IsoId=P54756-3; Sequence=VSP_039118, VSP_039119;
CC   -!- TISSUE SPECIFICITY: Almost exclusively expressed in the nervous
CC       system.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Ephrin receptor subfamily.
CC   -!- SIMILARITY: Contains 2 fibronectin type-III domains.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 SAM (sterile alpha motif) domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X95425; CAA64700.1; -; mRNA.
DR   EMBL; AC018683; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104137; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC105923; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC115223; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX537946; CAD97914.1; -; mRNA.
DR   EMBL; L36644; AAA74245.1; -; mRNA.
DR   IPI; IPI00008290; -.
DR   IPI; IPI00215945; -.
DR   IPI; IPI00964566; -.
DR   RefSeq; NP_004430.4; -.
DR   RefSeq; NP_872272.2; -.
DR   UniGene; Hs.654492; -.
DR   PDB; 2R2P; X-ray; 2.40 A; A=653-939.
DR   PDBsum; 2R2P; -.
DR   ProteinModelPortal; P54756; -.
DR   STRING; P54756; -.
DR   PhosphoSite; P54756; -.
DR   PRIDE; P54756; -.
DR   Ensembl; ENST00000273854; ENSP00000273854; ENSG00000145242.
DR   GeneID; 2044; -.
DR   KEGG; hsa:2044; -.
DR   UCSC; uc003hcy.1; human.
DR   UCSC; uc003hcz.1; human.
DR   CTD; 2044; -.
DR   GeneCards; GC04M066193; -.
DR   HGNC; HGNC:3389; EPHA5.
DR   MIM; 600004; gene.
DR   PharmGKB; PA27821; -.
DR   eggNOG; prNOG12339; -.
DR   HOVERGEN; HBG062180; -.
DR   InParanoid; P54756; -.
DR   OMA; WRCGYSK; -.
DR   BRENDA; 2.7.10.1; 247.
DR   Pathway_Interaction_DB; epha_fwdpathway; EPHA forward signaling.
DR   Pathway_Interaction_DB; ephrinarevpathway; Ephrin A reverse signaling.
DR   Pathway_Interaction_DB; ephrina_ephapathway; EphrinA-EPHA pathway.
DR   NextBio; 8305; -.
DR   ArrayExpress; P54756; -.
DR   Bgee; P54756; -.
DR   CleanEx; HS_EPHA5; -.
DR   Genevestigator; P54756; -.
DR   GermOnline; ENSG00000145242; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IEA:InterPro.
DR   GO; GO:0005005; F:transmembrane-ephrin receptor activity; TAS:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; TAS:UniProtKB.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kin...; IEA:InterPro.
DR   InterPro; IPR001090; Ephrin_rcpt_lig-bd.
DR   InterPro; IPR008957; Fibronectin_III_dom.
DR   InterPro; IPR003961; FN_III.
DR   InterPro; IPR008979; Galactose-bd-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM_type.
DR   InterPro; IPR021129; SAM_type1.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR010993; Sterile_alpha_motif_homology.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   InterPro; IPR020768; Tyr_prot_kinase_EphA_rcpt.
DR   InterPro; IPR016257; Tyr_prot_kinase_ephrin_rcpt.
DR   InterPro; IPR001426; Tyr_prot_kinase_rcpt_V_CS.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 2.
DR   Gene3D; G3DSA:1.10.150.50; SAM_type; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   PANTHER; PTHR23256:SF278; Tyr_prot_kinase_EphA_rcpt; 1.
DR   Pfam; PF01404; Ephrin_lbd; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00536; SAM_1; 1.
DR   PIRSF; PIRSF000666; TyrPK_ephrin_receptor; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00615; EPH_lbd; 1.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00454; SAM; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF49265; FN_III-like; 2.
DR   SUPFAM; SSF49785; Gal_bind_like; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF47769; SAM_homology; 1.
DR   PROSITE; PS01186; EGF_2; UNKNOWN_1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00790; RECEPTOR_TYR_KIN_V_1; 1.
DR   PROSITE; PS00791; RECEPTOR_TYR_KIN_V_2; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Glycoprotein; Kinase; Membrane; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Receptor; Repeat; Signal; Transferase; Transmembrane;
KW   Transmembrane helix; Tyrosine-protein kinase.
FT   SIGNAL        1     24       Potential.
FT   CHAIN        25   1037       Ephrin type-A receptor 5.
FT                                /FTId=PRO_0000016812.
FT   TOPO_DOM     25    573       Extracellular (Potential).
FT   TRANSMEM    574    594       Helical; (Potential).
FT   TOPO_DOM    595   1037       Cytoplasmic (Potential).
FT   DOMAIN      357    459       Fibronectin type-III 1.
FT   DOMAIN      469    559       Fibronectin type-III 2.
FT   DOMAIN      675    936       Protein kinase.
FT   DOMAIN      965   1029       SAM.
FT   NP_BIND     681    689       ATP (By similarity).
FT   MOTIF      1035   1037       PDZ-binding (Potential).
FT   COMPBIAS    220    354       Cys-rich.
FT   ACT_SITE    800    800       Proton acceptor (By similarity).
FT   BINDING     707    707       ATP (By similarity).
FT   MOD_RES     650    650       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     656    656       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     833    833       Phosphotyrosine; by autocatalysis
FT                                (Potential).
FT   MOD_RES     982    982       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   CARBOHYD    264    264       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    299    299       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    369    369       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    423    423       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    436    436       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    461    461       N-linked (GlcNAc...) (Potential).
FT   VAR_SEQ       1     69       Missing (in isoform 3).
FT                                /FTId=VSP_039118.
FT   VAR_SEQ     563    563       F -> SV (in isoform 3).
FT                                /FTId=VSP_039119.
FT   VAR_SEQ     597    619       SCCECGCGRASSLCAVAHPSLIW -> R (in isoform
FT                                2).
FT                                /FTId=VSP_002999.
FT   VARIANT      81     81       N -> T (in dbSNP:rs33932471).
FT                                /FTId=VAR_042138.
FT   VARIANT     235    235       S -> A (in dbSNP:rs55710198).
FT                                /FTId=VAR_042139.
FT   VARIANT     330    330       E -> Q (in dbSNP:rs56205382).
FT                                /FTId=VAR_042140.
FT   VARIANT     417    417       R -> Q (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_042141.
FT   VARIANT     503    503       E -> K (in a lung large cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042142.
FT   VARIANT     506    506       Y -> C (in dbSNP:rs56074660).
FT                                /FTId=VAR_045912.
FT   VARIANT     582    582       G -> E (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_042143.
FT   VARIANT     672    672       A -> T (in dbSNP:rs36050417).
FT                                /FTId=VAR_042144.
FT   VARIANT     673    673       S -> T (in dbSNP:rs56359290).
FT                                /FTId=VAR_042145.
FT   VARIANT     856    856       T -> I (in a lung squamous cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042146.
FT   VARIANT     959    959       H -> R (in dbSNP:rs56312931).
FT                                /FTId=VAR_042147.
FT   VARIANT    1032   1032       N -> S (in a lung large cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042148.
FT   CONFLICT     11     11       R -> H (in Ref. 1; CAA64700).
FT   CONFLICT     87     87       G -> D (in Ref. 3; CAD97914).
FT   CONFLICT    506    506       Y -> H (in Ref. 1; CAA64700).
FT   CONFLICT    611    611       A -> V (in Ref. 3; CAD97914).
FT   CONFLICT    616    616       S -> I (in Ref. 1; CAA64700).
FT   CONFLICT    820    820       G -> E (in Ref. 3; CAD97914).
FT   HELIX       663    665
FT   HELIX       672    674
FT   STRAND      675    683
FT   STRAND      685    694
FT   STRAND      702    708
FT   HELIX       715    728
FT   STRAND      739    743
FT   STRAND      745    748
FT   STRAND      750    754
FT   HELIX       761    766
FT   TURN        767    770
FT   HELIX       774    793
FT   HELIX       803    805
FT   STRAND      806    808
FT   STRAND      814    816
FT   HELIX       842    844
FT   HELIX       847    852
FT   HELIX       857    873
FT   TURN        878    881
FT   HELIX       884    893
FT   HELIX       905    914
FT   HELIX       919    921
FT   HELIX       925    936
SQ   SEQUENCE   1037 AA;  114803 MW;  578C2F4D950DE419 CRC64;
     MRGSGPRGAG RRRPPSGGGD TPITPASLAG CYSAPRRAPL WTCLLLCAAL RTLLASPSNE
     VNLLDSRTVM GDLGWIAFPK NGWEEIGEVD ENYAPIHTYQ VCKVMEQNQN NWLLTSWISN
     EGASRIFIEL KFTLRDCNSL PGGLGTCKET FNMYYFESDD QNGRNIKENQ YIKIDTIAAD
     ESFTELDLGD RVMKLNTEVR DVGPLSKKGF YLAFQDVGAC IALVSVRVYY KKCPSVVRHL
     AVFPDTITGA DSSQLLEVSG SCVNHSVTDE PPKMHCSAEG EWLVPIGKCM CKAGYEEKNG
     TCQVCRPGFF KASPHIQSCG KCPPHSYTHE EASTSCVCEK DYFRRESDPP TMACTRPPSA
     PRNAISNVNE TSVFLEWIPP ADTGGRKDVS YYIACKKCNS HAGVCEECGG HVRYLPRQSG
     LKNTSVMMVD LLAHTNYTFE IEAVNGVSDL SPGARQYVSV NVTTNQAAPS PVTNVKKGKI
     AKNSISLSWQ EPDRPNGIIL EYEIKYFEKD QETSYTIIKS KETTITAEGL KPASVYVFQI
     RARTAAGYGV FSRRFEFETT PVFAASSDQS QIPVIAVSVT VGVILLAVVI GVLLSGSCCE
     CGCGRASSLC AVAHPSLIWR CGYSKAKQDP EEEKMHFHNG HIKLPGVRTY IDPHTYEDPN
     QAVHEFAKEI EASCITIERV IGAGEFGEVC SGRLKLPGKR ELPVAIKTLK VGYTEKQRRD
     FLGEASIMGQ FDHPNIIHLE GVVTKSKPVM IVTEYMENGS LDTFLKKNDG QFTVIQLVGM
     LRGISAGMKY LSDMGYVHRD LAARNILINS NLVCKVSDFG LSRVLEDDPE AAYTTRGGKI
     PIRWTAPEAI AFRKFTSASD VWSYGIVMWE VVSYGERPYW EMTNQDVIKA VEEGYRLPSP
     MDCPAALYQL MLDCWQKERN SRPKFDEIVN MLDKLIRNPS SLKTLVNASC RVSNLLAEHS
     PLGSGAYRSV GEWLEAIKMG RYTEIFMENG YSSMDAVAQV TLEDLRRLGV TLVGHQKKIM
     NSLQEMKVQL VNGMVPL
//
